RAY CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13,690 KRW | -2.14% |
|
-12.24% | -40.09% |
| Sales 2024 * | 157B 114M | Sales 2025 * | 229B 166M | Capitalization | 214B 155M |
|---|---|---|---|---|---|
| Net income 2024 * | 12B 8.7M | Net income 2025 * | 34B 24.65M | EV / Sales 2024 * | 1.59 x |
| Net Debt 2024 * | 36B 26.1M | Net Debt 2025 * | 27.8B 20.16M | EV / Sales 2025 * | 1.05 x |
| P/E ratio 2024 * |
18.1
x | P/E ratio 2025 * |
6.21
x | Employees | 218 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 70.89% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.30% | ||
| 1 week | -10.32% | ||
| Current month | -12.23% | ||
| 1 month | -20.15% | ||
| 3 months | -36.84% | ||
| 6 months | -37.12% | ||
| Current year | -38.77% |
1 week
13 760.00
15 130.00
1 month
13 760.0017 500.00
Current year
13 760.0025 100.00
1 year
13 760.0042 150.00
3 years
13 760.0042 150.00
5 years
11 825.0042 150.00
10 years
11 825.0042 150.00
| Managers | Title | Age | Since |
|---|---|---|---|
Sang-Chul Lee
FOU | Founder | 51 | 04-10-05 |
Hyung-Joon Jo
CTO | Chief Tech/Sci/R&D Officer | 51 | 08-05-31 |
Yong-Gyu Lee
SAM | Sales & Marketing | 50 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Sang-Chul Lee
FOU | Founder | 51 | 04-10-05 |
Hyung-Joon Jo
CTO | Chief Tech/Sci/R&D Officer | 51 | 08-05-31 |
Cheol-Woo Jung
BRD | Director/Board Member | 52 | 06-09-30 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-18 | 13,690 | -2.14% | 128 537 |
| 24-04-18 | 13,990 | +1.30% | 85,448 |
| 24-04-17 | 13,810 | -1.57% | 94,276 |
| 24-04-16 | 14,030 | -5.97% | 219,818 |
| 24-04-15 | 14,920 | -2.42% | 131,202 |
End-of-day quote Korea S.E., April 17, 2024
More quotes
Ray Co.,Ltd is a Korea-based company mainly engaged in the development, production and distribution of dental imaging medical devices. Along with its subsidiaries, the Company manufactures and sells digital diagnostic systems and digital therapy solution products. Digital diagnostic systems include dental radiography equipments such as x-ray systems and cone beam computed tomography (CBCT) systems. Digital therapy solutions include three dimensional (3D) scanning, dental computer aided design (CAD), and 3D printers used in prosthodontics, orthodontics, and implant surgery. The Company distributes its products within domestic market and to overseas markets.
Calendar
2024-05-08
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
13,990
KRW
Average target price
35,000
KRW
Spread / Average Target
+150.18%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -38.77% | 155M | |
| -10.31% | 13.99B | |
| -40.33% | 2.73B | |
| -20.66% | 2.23B | |
| -15.69% | 1.4B | |
| +42.39% | 524M | |
| +69.49% | 445M | |
| -3.65% | 216M | |
| +1.11% | 182M | |
| -.--% | 168M |
- Stock Market
- Equities
- A228670 Stock
